Hematology
Credibility 80
Outcomes of GLP-1 receptor agonist therapy in adults with sickle cell disease and type 2 diabetes: a real-world cohort analysis.
March 28, 2026 · Orphanet journal of rare diseases
Key takeaway
For Black adults with sickle cell and type 2 diabetes, a diabetes medication called GLP-1 was found to reduce serious heart problems, strokes, and sickle cell pain crises. This is important because it suggests this medicine might offer extra protection for our community.
Why this matters for our communities
Research in hematology helps close long-standing gaps in how Black and African American families are studied, diagnosed, and cared for. Use findings like this one to start informed conversations with your care team — not as a substitute for personal medical advice.
More in Hematology
October 13, 2026Arginine Therapy for Sickle Cell Disease Acute Pain Episodes: The STArT Randomized Clinical Trial.Read August 24, 2026Experiences of family building counseling and perceptions of reproductive technology among adults with sickle cell disease.Read August 20, 2026Risk of infertility among women with sickle cell disease.Read